Skip to content

Form 4 filed by Venrock Healthcare Capital Partners III, L.P.

Venrock Healthcare Capital Partners III, L.P. filed this Form 4 on Lycia Therapeutics, Inc. with 9 transaction rows and 0 holding rows, accepted by EDGAR 2026-10-27 22:38:10 UTC.

Accession
0001231919-26-001503
Filed
2026-10-27
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Issuer and reporting owners

Issuer: Lycia Therapeutics, Inc. (CIK 1806540)

Rows

SecurityDateCodeSharesPriceOwned afterOwnership
Common Stock 2026-10-23P bought+24,560$25.6824,560I By Funds
Common Stock 2026-10-23P bought+28,379$26.1152,939I By Funds
Common Stock 2026-10-26C converted+4,779,7934,832,732I By Funds
Common Stock 2026-10-26P bought+1,944,444$186,777,176I By Funds
Common Stock 2026-10-26P bought+8,261$26.976,785,437I By Funds
Common Stock 2026-10-27P bought+8,729$25.846,794,166I By Funds
Common Stock 2026-10-27P bought+31,067$26.846,825,233I By Funds
Series C Preferred Stock derivative2026-10-26C converted-17,142,578$00I By Funds
Series D Preferred Stock derivative2026-10-26C converted-4,408,091$00I By Funds